Back to Search Start Over

Molecular and clinical pharmacology of psoriasis

Molecular and clinical pharmacology of psoriasis

Authors :
Voorhees, John J.
Duell, Elizabeth A.
Stawiski, Marek
Harrell, E. Richard
Source :
Clinical Pharmacology & Therapeutics; Part 16/November 1974, Vol. 16 Issue: 5 p919-921, 3p
Publication Year :
1974

Abstract

Psoriasis appears in most cases to be a genetic disease8in which stratified squamous epithelium (epidermis) of skin in involved versus normalā€appearing uninvolved areas has the following prototypic features: (1) excessive cell proliferation and an accelerated cell cycle of the proliferating cells21; (2) incomplete epidermal specialization (keratinization) for tissue function; and (3) marked increase in glycogen content.7It has been widely held that the relative lack of epidermal specialization is due to the rapid transit of cells through the epidermis (i.e., the cells are shed from the patient without sufficient time for normal keratinization to occur). However, an alternate explanation is that the excessive cell proliferation is the result of an inability of differentiated basal cells to make the commitment of specialization. For this reason we have listed incomplete specialization as one of the three characteristic findings in psoriasis lesions.

Details

Language :
English
ISSN :
00099236 and 15326535
Volume :
16
Issue :
5
Database :
Supplemental Index
Journal :
Clinical Pharmacology & Therapeutics
Publication Type :
Periodical
Accession number :
ejs41228174
Full Text :
https://doi.org/10.1002/cpt1974165part2919